OM Group to exit cobalt business


US speciality chemicals firm OM Group has signed a deal to sell its cobalt business for up to $435 million (£280 million) to a joint venture between Freeport-McMoRan Copper & Gold, Lundin Mining and Gécamines. The deal includes downstream activities, in particular cobalt refining in Kokkola, Finland.

OM Group will receive $325 million up front and a further $110 million if and when commercial targets are achieved.

After the sale, the company expects to have $500 million in cash, which it will use to clear ‘a substantial portion’ of its debt. It will also look to strengthen its position in growth markets including the automotive systems, electronic devices, aerospace, general industrial and renewable energy markets.

‘The divestiture of our cobalt business is the final step in exiting our legacy commodity businesses and is consistent with our strategy to move up the value chain into technology-based businesses with attractive growth prospects and more predictable earnings profiles,’ said Joe Scaminace, chairman and chief executive of OM Group.


Related Content

Tough tungsten alloy produces purer nanotubes

27 June 2014 Research

news image

Heat stable catalyst grows carbon nanotubes with 90% uniform chirality

Alfred Werner: the well-coordinated chemist

26 February 2013 Premium contentFeature

news image

Werner’s careful experiments led to the discovery of what came to be known as coordination bonds

Most Read

Antimicrobial resistance will kill 300 million by 2050 without action

16 December 2014 News and Analysis

news image

UK report says resistance will cost global economy $100 trillion

Cutting edge chemistry in 2014

10 December 2014 Research

news image

We take a look back at the year's most interesting chemical science stories

Most Commented

Smart skin for prosthetic limbs senses heat and touch

12 December 2014 Research

news image

Ultra-thin plastic skin can bend and flex without affecting the skin's ability to detect stimuli

Chemistry behind the ‘blue man’ unlocked

1 November 2012 Research

news image

Biochemical model suggests that silver ions, not nanoparticles, cause a rare skin complaint